Atlas Trials

Tolerability and Safety of Nintedanib in Myositis Associated Interstitial Lung Disease

Clinical trial NCT05335278 · TERMINATED

Trial details

NCT number
NCT05335278
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Interstitial Lung DiseaseMyopathy, Inflammatory
Start date
2021-06-01
Primary completion
2024-12-31
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.